Our studies showed that lung tumors generated by a tail vein injection of lung cancer cells and a LPS-induced lung inflammation decrease Slit2 expression in the lungs, while lung tumors formed in a transgenic RasG12D animal model increase Slit2 expression, mostly the Slit2-WT form. Here, SLIT2 is linked to lung carcinoma.